Vials for COVID-19 Vaccine Market
1 Study Coverage
1.1 Vials for COVID-19 Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Vials for COVID-19 Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Middle-borate Borosilicate Glass
1.2.3 Low-borate Borosilicate Glass
1.3 Market by Application
1.3.1 Global Vials for COVID-19 Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Vaccine Manufacturing
1.3.3 Vaccine Researching
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vials for COVID-19 Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Vials for COVID-19 Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Vials for COVID-19 Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Vials for COVID-19 Vaccine Sales by Region
2.4.1 Global Vials for COVID-19 Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Vials for COVID-19 Vaccine by Region (2023-2028)
2.5 Global Vials for COVID-19 Vaccine Revenue by Region
2.5.1 Global Vials for COVID-19 Vaccine Revenue by Region (2017-2022)
2.5.2 Global Vials for COVID-19 Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Vials for COVID-19 Vaccine Sales by Manufacturers
3.1.1 Global Top Vials for COVID-19 Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Vials for COVID-19 Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vials for COVID-19 Vaccine in 2021
3.2 Global Vials for COVID-19 Vaccine Revenue by Manufacturers
3.2.1 Global Vials for COVID-19 Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Vials for COVID-19 Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Vials for COVID-19 Vaccine Revenue in 2021
3.3 Global Vials for COVID-19 Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Vials for COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Vials for COVID-19 Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vials for COVID-19 Vaccine Sales by Type
4.1.1 Global Vials for COVID-19 Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Vials for COVID-19 Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Vials for COVID-19 Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Vials for COVID-19 Vaccine Revenue by Type
4.2.1 Global Vials for COVID-19 Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Vials for COVID-19 Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Vials for COVID-19 Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Vials for COVID-19 Vaccine Price by Type
4.3.1 Global Vials for COVID-19 Vaccine Price by Type (2017-2022)
4.3.2 Global Vials for COVID-19 Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Vials for COVID-19 Vaccine Sales by Application
5.1.1 Global Vials for COVID-19 Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Vials for COVID-19 Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Vials for COVID-19 Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Vials for COVID-19 Vaccine Revenue by Application
5.2.1 Global Vials for COVID-19 Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Vials for COVID-19 Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Vials for COVID-19 Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Vials for COVID-19 Vaccine Price by Application
5.3.1 Global Vials for COVID-19 Vaccine Price by Application (2017-2022)
5.3.2 Global Vials for COVID-19 Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Vials for COVID-19 Vaccine Market Size by Type
6.1.1 North America Vials for COVID-19 Vaccine Sales by Type (2017-2028)
6.1.2 North America Vials for COVID-19 Vaccine Revenue by Type (2017-2028)
6.2 North America Vials for COVID-19 Vaccine Market Size by Application
6.2.1 North America Vials for COVID-19 Vaccine Sales by Application (2017-2028)
6.2.2 North America Vials for COVID-19 Vaccine Revenue by Application (2017-2028)
6.3 North America Vials for COVID-19 Vaccine Market Size by Country
6.3.1 North America Vials for COVID-19 Vaccine Sales by Country (2017-2028)
6.3.2 North America Vials for COVID-19 Vaccine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Vials for COVID-19 Vaccine Market Size by Type
7.1.1 Europe Vials for COVID-19 Vaccine Sales by Type (2017-2028)
7.1.2 Europe Vials for COVID-19 Vaccine Revenue by Type (2017-2028)
7.2 Europe Vials for COVID-19 Vaccine Market Size by Application
7.2.1 Europe Vials for COVID-19 Vaccine Sales by Application (2017-2028)
7.2.2 Europe Vials for COVID-19 Vaccine Revenue by Application (2017-2028)
7.3 Europe Vials for COVID-19 Vaccine Market Size by Country
7.3.1 Europe Vials for COVID-19 Vaccine Sales by Country (2017-2028)
7.3.2 Europe Vials for COVID-19 Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vials for COVID-19 Vaccine Market Size by Type
8.1.1 Asia Pacific Vials for COVID-19 Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Vials for COVID-19 Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Vials for COVID-19 Vaccine Market Size by Application
8.2.1 Asia Pacific Vials for COVID-19 Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Vials for COVID-19 Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Vials for COVID-19 Vaccine Market Size by Region
8.3.1 Asia Pacific Vials for COVID-19 Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Vials for COVID-19 Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Vials for COVID-19 Vaccine Market Size by Type
9.1.1 Latin America Vials for COVID-19 Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Vials for COVID-19 Vaccine Revenue by Type (2017-2028)
9.2 Latin America Vials for COVID-19 Vaccine Market Size by Application
9.2.1 Latin America Vials for COVID-19 Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Vials for COVID-19 Vaccine Revenue by Application (2017-2028)
9.3 Latin America Vials for COVID-19 Vaccine Market Size by Country
9.3.1 Latin America Vials for COVID-19 Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Vials for COVID-19 Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vials for COVID-19 Vaccine Market Size by Type
10.1.1 Middle East and Africa Vials for COVID-19 Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Vials for COVID-19 Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Vials for COVID-19 Vaccine Market Size by Application
10.2.1 Middle East and Africa Vials for COVID-19 Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Vials for COVID-19 Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Vials for COVID-19 Vaccine Market Size by Country
10.3.1 Middle East and Africa Vials for COVID-19 Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Vials for COVID-19 Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Corning
11.1.1 Corning Corporation Information
11.1.2 Corning Overview
11.1.3 Corning Vials for COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Corning Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Corning Recent Developments
11.2 Schott AG
11.2.1 Schott AG Corporation Information
11.2.2 Schott AG Overview
11.2.3 Schott AG Vials for COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Schott AG Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Schott AG Recent Developments
11.3 SiO2 Materials Science
11.3.1 SiO2 Materials Science Corporation Information
11.3.2 SiO2 Materials Science Overview
11.3.3 SiO2 Materials Science Vials for COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 SiO2 Materials Science Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 SiO2 Materials Science Recent Developments
11.4 SGD Pharma
11.4.1 SGD Pharma Corporation Information
11.4.2 SGD Pharma Overview
11.4.3 SGD Pharma Vials for COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 SGD Pharma Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 SGD Pharma Recent Developments
11.5 Stevanato Group
11.5.1 Stevanato Group Corporation Information
11.5.2 Stevanato Group Overview
11.5.3 Stevanato Group Vials for COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Stevanato Group Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Stevanato Group Recent Developments
11.6 DWK Life Sciences
11.6.1 DWK Life Sciences Corporation Information
11.6.2 DWK Life Sciences Overview
11.6.3 DWK Life Sciences Vials for COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 DWK Life Sciences Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 DWK Life Sciences Recent Developments
11.7 Gerresheimer
11.7.1 Gerresheimer Corporation Information
11.7.2 Gerresheimer Overview
11.7.3 Gerresheimer Vials for COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Gerresheimer Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Gerresheimer Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vials for COVID-19 Vaccine Industry Chain Analysis
12.2 Vials for COVID-19 Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vials for COVID-19 Vaccine Production Mode & Process
12.4 Vials for COVID-19 Vaccine Sales and Marketing
12.4.1 Vials for COVID-19 Vaccine Sales Channels
12.4.2 Vials for COVID-19 Vaccine Distributors
12.5 Vials for COVID-19 Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Vials for COVID-19 Vaccine Industry Trends
13.2 Vials for COVID-19 Vaccine Market Drivers
13.3 Vials for COVID-19 Vaccine Market Challenges
13.4 Vials for COVID-19 Vaccine Market Restraints
14 Key Findings in The Global Vials for COVID-19 Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Vials for COVID-19 Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Middle-borate Borosilicate Glass
Table 3. Major Manufacturers of Low-borate Borosilicate Glass
Table 4. Global Vials for COVID-19 Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Vials for COVID-19 Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Vials for COVID-19 Vaccine Sales by Region (2017-2022) & (Million Units)
Table 7. Global Vials for COVID-19 Vaccine Sales Market Share by Region (2017-2022)
Table 8. Global Vials for COVID-19 Vaccine Sales by Region (2023-2028) & (Million Units)
Table 9. Global Vials for COVID-19 Vaccine Sales Market Share by Region (2023-2028)
Table 10. Global Vials for COVID-19 Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Vials for COVID-19 Vaccine Revenue Market Share by Region (2017-2022)
Table 12. Global Vials for COVID-19 Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Vials for COVID-19 Vaccine Revenue Market Share by Region (2023-2028)
Table 14. Global Vials for COVID-19 Vaccine Sales by Manufacturers (2017-2022) & (Million Units)
Table 15. Global Vials for COVID-19 Vaccine Sales Share by Manufacturers (2017-2022)
Table 16. Global Vials for COVID-19 Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Vials for COVID-19 Vaccine Revenue Share by Manufacturers (2017-2022)
Table 18. Vials for COVID-19 Vaccine Price by Manufacturers (2017-2022) &(US$/K Units)
Table 19. Global Vials for COVID-19 Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Vials for COVID-19 Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vials for COVID-19 Vaccine as of 2021)
Table 21. Vials for COVID-19 Vaccine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Vials for COVID-19 Vaccine Product Offered
Table 23. Date of Manufacturers Enter into Vials for COVID-19 Vaccine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Vials for COVID-19 Vaccine Sales by Type (2017-2022) & (Million Units)
Table 26. Global Vials for COVID-19 Vaccine Sales by Type (2023-2028) & (Million Units)
Table 27. Global Vials for COVID-19 Vaccine Sales Share by Type (2017-2022)
Table 28. Global Vials for COVID-19 Vaccine Sales Share by Type (2023-2028)
Table 29. Global Vials for COVID-19 Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Vials for COVID-19 Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Vials for COVID-19 Vaccine Revenue Share by Type (2017-2022)
Table 32. Global Vials for COVID-19 Vaccine Revenue Share by Type (2023-2028)
Table 33. Vials for COVID-19 Vaccine Price by Type (2017-2022) & (US$/K Units)
Table 34. Global Vials for COVID-19 Vaccine Price Forecast by Type (2023-2028) & (US$/K Units)
Table 35. Global Vials for COVID-19 Vaccine Sales by Application (2017-2022) & (Million Units)
Table 36. Global Vials for COVID-19 Vaccine Sales by Application (2023-2028) & (Million Units)
Table 37. Global Vials for COVID-19 Vaccine Sales Share by Application (2017-2022)
Table 38. Global Vials for COVID-19 Vaccine Sales Share by Application (2023-2028)
Table 39. Global Vials for COVID-19 Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Vials for COVID-19 Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Vials for COVID-19 Vaccine Revenue Share by Application (2017-2022)
Table 42. Global Vials for COVID-19 Vaccine Revenue Share by Application (2023-2028)
Table 43. Vials for COVID-19 Vaccine Price by Application (2017-2022) & (US$/K Units)
Table 44. Global Vials for COVID-19 Vaccine Price Forecast by Application (2023-2028) & (US$/K Units)
Table 45. North America Vials for COVID-19 Vaccine Sales by Type (2017-2022) & (Million Units)
Table 46. North America Vials for COVID-19 Vaccine Sales by Type (2023-2028) & (Million Units)
Table 47. North America Vials for COVID-19 Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Vials for COVID-19 Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Vials for COVID-19 Vaccine Sales by Application (2017-2022) & (Million Units)
Table 50. North America Vials for COVID-19 Vaccine Sales by Application (2023-2028) & (Million Units)
Table 51. North America Vials for COVID-19 Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Vials for COVID-19 Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Vials for COVID-19 Vaccine Sales by Country (2017-2022) & (Million Units)
Table 54. North America Vials for COVID-19 Vaccine Sales by Country (2023-2028) & (Million Units)
Table 55. North America Vials for COVID-19 Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Vials for COVID-19 Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Vials for COVID-19 Vaccine Sales by Type (2017-2022) & (Million Units)
Table 58. Europe Vials for COVID-19 Vaccine Sales by Type (2023-2028) & (Million Units)
Table 59. Europe Vials for COVID-19 Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Vials for COVID-19 Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Vials for COVID-19 Vaccine Sales by Application (2017-2022) & (Million Units)
Table 62. Europe Vials for COVID-19 Vaccine Sales by Application (2023-2028) & (Million Units)
Table 63. Europe Vials for COVID-19 Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Vials for COVID-19 Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Vials for COVID-19 Vaccine Sales by Country (2017-2022) & (Million Units)
Table 66. Europe Vials for COVID-19 Vaccine Sales by Country (2023-2028) & (Million Units)
Table 67. Europe Vials for COVID-19 Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Vials for COVID-19 Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Vials for COVID-19 Vaccine Sales by Type (2017-2022) & (Million Units)
Table 70. Asia Pacific Vials for COVID-19 Vaccine Sales by Type (2023-2028) & (Million Units)
Table 71. Asia Pacific Vials for COVID-19 Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Vials for COVID-19 Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Vials for COVID-19 Vaccine Sales by Application (2017-2022) & (Million Units)
Table 74. Asia Pacific Vials for COVID-19 Vaccine Sales by Application (2023-2028) & (Million Units)
Table 75. Asia Pacific Vials for COVID-19 Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Vials for COVID-19 Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Vials for COVID-19 Vaccine Sales by Region (2017-2022) & (Million Units)
Table 78. Asia Pacific Vials for COVID-19 Vaccine Sales by Region (2023-2028) & (Million Units)
Table 79. Asia Pacific Vials for COVID-19 Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Vials for COVID-19 Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Vials for COVID-19 Vaccine Sales by Type (2017-2022) & (Million Units)
Table 82. Latin America Vials for COVID-19 Vaccine Sales by Type (2023-2028) & (Million Units)
Table 83. Latin America Vials for COVID-19 Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Vials for COVID-19 Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Vials for COVID-19 Vaccine Sales by Application (2017-2022) & (Million Units)
Table 86. Latin America Vials for COVID-19 Vaccine Sales by Application (2023-2028) & (Million Units)
Table 87. Latin America Vials for COVID-19 Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Vials for COVID-19 Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Vials for COVID-19 Vaccine Sales by Country (2017-2022) & (Million Units)
Table 90. Latin America Vials for COVID-19 Vaccine Sales by Country (2023-2028) & (Million Units)
Table 91. Latin America Vials for COVID-19 Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Vials for COVID-19 Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Vials for COVID-19 Vaccine Sales by Type (2017-2022) & (Million Units)
Table 94. Middle East and Africa Vials for COVID-19 Vaccine Sales by Type (2023-2028) & (Million Units)
Table 95. Middle East and Africa Vials for COVID-19 Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Vials for COVID-19 Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Vials for COVID-19 Vaccine Sales by Application (2017-2022) & (Million Units)
Table 98. Middle East and Africa Vials for COVID-19 Vaccine Sales by Application (2023-2028) & (Million Units)
Table 99. Middle East and Africa Vials for COVID-19 Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Vials for COVID-19 Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Vials for COVID-19 Vaccine Sales by Country (2017-2022) & (Million Units)
Table 102. Middle East and Africa Vials for COVID-19 Vaccine Sales by Country (2023-2028) & (Million Units)
Table 103. Middle East and Africa Vials for COVID-19 Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Vials for COVID-19 Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Corning Corporation Information
Table 106. Corning Description and Major Businesses
Table 107. Corning Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 108. Corning Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Corning Recent Developments
Table 110. Schott AG Corporation Information
Table 111. Schott AG Description and Major Businesses
Table 112. Schott AG Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 113. Schott AG Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Schott AG Recent Developments
Table 115. SiO2 Materials Science Corporation Information
Table 116. SiO2 Materials Science Description and Major Businesses
Table 117. SiO2 Materials Science Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 118. SiO2 Materials Science Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. SiO2 Materials Science Recent Developments
Table 120. SGD Pharma Corporation Information
Table 121. SGD Pharma Description and Major Businesses
Table 122. SGD Pharma Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 123. SGD Pharma Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. SGD Pharma Recent Developments
Table 125. Stevanato Group Corporation Information
Table 126. Stevanato Group Description and Major Businesses
Table 127. Stevanato Group Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 128. Stevanato Group Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Stevanato Group Recent Developments
Table 130. DWK Life Sciences Corporation Information
Table 131. DWK Life Sciences Description and Major Businesses
Table 132. DWK Life Sciences Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 133. DWK Life Sciences Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. DWK Life Sciences Recent Developments
Table 135. Gerresheimer Corporation Information
Table 136. Gerresheimer Description and Major Businesses
Table 137. Gerresheimer Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 138. Gerresheimer Vials for COVID-19 Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Gerresheimer Recent Developments
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Vials for COVID-19 Vaccine Distributors List
Table 143. Vials for COVID-19 Vaccine Customers List
Table 144. Vials for COVID-19 Vaccine Market Trends
Table 145. Vials for COVID-19 Vaccine Market Drivers
Table 146. Vials for COVID-19 Vaccine Market Challenges
Table 147. Vials for COVID-19 Vaccine Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Vials for COVID-19 Vaccine Product Picture
Figure 3. Global Vials for COVID-19 Vaccine Market Share by Type in 2021 & 2028
Figure 3. Middle-borate Borosilicate Glass Product Picture
Figure 4. Low-borate Borosilicate Glass Product Picture
Figure 5. Global Vials for COVID-19 Vaccine Market Share by Application in 2021 & 2028
Figure 6. Vaccine Manufacturing
Figure 7. Vaccine Researching
Figure 8. Vials for COVID-19 Vaccine Report Years Considered
Figure 9. Global Vials for COVID-19 Vaccine Sales 2017-2028 (Million Units)
Figure 10. Global Vials for COVID-19 Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Vials for COVID-19 Vaccine Revenue 2017-2028 (US$ Million)
Figure 12. Global Vials for COVID-19 Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Vials for COVID-19 Vaccine Sales Market Share by Region (2017-2022)
Figure 14. Global Vials for COVID-19 Vaccine Sales Market Share by Region (2023-2028)
Figure 15. North America Vials for COVID-19 Vaccine Sales YoY (2017-2028) & (Million Units)
Figure 16. North America Vials for COVID-19 Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Vials for COVID-19 Vaccine Sales YoY (2017-2028) & (Million Units)
Figure 18. Europe Vials for COVID-19 Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Vials for COVID-19 Vaccine Sales YoY (2017-2028) & (Million Units)
Figure 20. Asia-Pacific Vials for COVID-19 Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Vials for COVID-19 Vaccine Sales YoY (2017-2028) & (Million Units)
Figure 22. Latin America Vials for COVID-19 Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Vials for COVID-19 Vaccine Sales YoY (2017-2028) & (Million Units)
Figure 24. Middle East & Africa Vials for COVID-19 Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Vials for COVID-19 Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Vials for COVID-19 Vaccine in the World: Market Share by Vials for COVID-19 Vaccine Revenue in 2021
Figure 27. Global Vials for COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Vials for COVID-19 Vaccine Sales Market Share by Type (2017-2028)
Figure 29. Global Vials for COVID-19 Vaccine Revenue Market Share by Type (2017-2028)
Figure 30. Global Vials for COVID-19 Vaccine Sales Market Share by Application (2017-2028)
Figure 31. Global Vials for COVID-19 Vaccine Revenue Market Share by Application (2017-2028)
Figure 32. North America Vials for COVID-19 Vaccine Sales Market Share by Type (2017-2028)
Figure 33. North America Vials for COVID-19 Vaccine Revenue Market Share by Type (2017-2028)
Figure 34. North America Vials for COVID-19 Vaccine Sales Market Share by Application (2017-2028)
Figure 35. North America Vials for COVID-19 Vaccine Revenue Market Share by Application (2017-2028)
Figure 36. North America Vials for COVID-19 Vaccine Sales Share by Country (2017-2028)
Figure 37. North America Vials for COVID-19 Vaccine Revenue Share by Country (2017-2028)
Figure 38. United States Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Vials for COVID-19 Vaccine Sales Market Share by Type (2017-2028)
Figure 41. Europe Vials for COVID-19 Vaccine Revenue Market Share by Type (2017-2028)
Figure 42. Europe Vials for COVID-19 Vaccine Sales Market Share by Application (2017-2028)
Figure 43. Europe Vials for COVID-19 Vaccine Revenue Market Share by Application (2017-2028)
Figure 44. Europe Vials for COVID-19 Vaccine Sales Share by Country (2017-2028)
Figure 45. Europe Vials for COVID-19 Vaccine Revenue Share by Country (2017-2028)
Figure 46. Germany Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 47. France Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Vials for COVID-19 Vaccine Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Vials for COVID-19 Vaccine Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Vials for COVID-19 Vaccine Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Vials for COVID-19 Vaccine Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Vials for COVID-19 Vaccine Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Vials for COVID-19 Vaccine Revenue Share by Region (2017-2028)
Figure 57. China Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 60. India Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Vials for COVID-19 Vaccine Sales Market Share by Type (2017-2028)
Figure 67. Latin America Vials for COVID-19 Vaccine Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Vials for COVID-19 Vaccine Sales Market Share by Application (2017-2028)
Figure 69. Latin America Vials for COVID-19 Vaccine Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Vials for COVID-19 Vaccine Sales Share by Country (2017-2028)
Figure 71. Latin America Vials for COVID-19 Vaccine Revenue Share by Country (2017-2028)
Figure 72. Mexico Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 75. Middle East and Africa Vials for COVID-19 Vaccine Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Vials for COVID-19 Vaccine Revenue Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Vials for COVID-19 Vaccine Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Vials for COVID-19 Vaccine Revenue Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Vials for COVID-19 Vaccine Sales Share by Country (2017-2028)
Figure 80. Middle East and Africa Vials for COVID-19 Vaccine Revenue Share by Country (2017-2028)
Figure 81. Turkey Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 82. Saudi Arabia Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 83. UAE Vials for COVID-19 Vaccine Revenue (2017-2028) & (US$ Million)
Figure 84. Vials for COVID-19 Vaccine Value Chain
Figure 85. Vials for COVID-19 Vaccine Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
Industry Market Size
